- Home
- CCBG vs CRGX Comparison
CCBG vs CRGX Comparison
Compare CCBG & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCBG
- CRGX
- Stock Information
- Founded
- CCBG 1895
- CRGX 2021
- Country
- CCBG United States
- CRGX United States
- Employees
- CCBG N/A
- CRGX N/A
- Industry
- CCBG Major Banks
- CRGX
- Sector
- CCBG Finance
- CRGX
- Exchange
- CCBG Nasdaq
- CRGX Nasdaq
- Market Cap
- CCBG 701.6M
- CRGX 190.0M
- IPO Year
- CCBG N/A
- CRGX 2023
- Fundamental
- Price
- CCBG $41.29
- CRGX $4.57
- Analyst Decision
- CCBG Buy
- CRGX Hold
- Analyst Count
- CCBG 2
- CRGX 7
- Target Price
- CCBG $39.00
- CRGX $5.33
- AVG Volume (30 Days)
- CCBG 44.2K
- CRGX 2.2M
- Earning Date
- CCBG 07-22-2025
- CRGX 08-11-2025
- Dividend Yield
- CCBG 2.31%
- CRGX N/A
- EPS Growth
- CCBG 11.98
- CRGX N/A
- EPS
- CCBG 3.37
- CRGX N/A
- Revenue
- CCBG $236,037,000.00
- CRGX N/A
- Revenue This Year
- CCBG $10.45
- CRGX $57.81
- Revenue Next Year
- CCBG $3.50
- CRGX N/A
- P/E Ratio
- CCBG $12.34
- CRGX N/A
- Revenue Growth
- CCBG 6.63
- CRGX N/A
- 52 Week Low
- CCBG $30.99
- CRGX $3.00
- 52 Week High
- CCBG $42.00
- CRGX $25.45
- Technical
- Relative Strength Index (RSI)
- CCBG 64.78
- CRGX 59.89
- Support Level
- CCBG $40.26
- CRGX $4.56
- Resistance Level
- CCBG $41.59
- CRGX $4.63
- Average True Range (ATR)
- CCBG 0.87
- CRGX 0.11
- MACD
- CCBG 0.06
- CRGX 0.02
- Stochastic Oscillator
- CCBG 97.71
- CRGX 74.24
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.